This package is designed to be used in the clinical area as a self directed learning tool.
The package is divided into sections. At the end of each section is a self test to determine how well you have understood the information contained in that section. You will need to complete the self tests at the end of each section and ensure that you have mastered the content before moving on to the next section.
If you have any trouble with the self test, go back over the section and revise the content. If you are still unsure then you will need to speak with one of the educators in your area.
The answers to each of the self test questions are contained at the end of the package. To gain the most benefit from this package attempt the questions first before seeking this reference.
GOOD LUCK!!!
Learning package objectives
By the completion of this package, the registered nurse will be able to:
1. Define and classify acute renal failure according to its aetiology 2. Identify the signs and symptoms of acute renal failure 3. Discuss the various modalities of renal replacement therapy including advantages and disadvantages 4. Identify the indications for continuous renal replacement therapy 5. Describe the basic principles of fluid and waste removal involved in CRRT 6. Describe the various modes of CRRT 7. Recognise the importance of access in CRRT 8. Explain the process for troubleshooting a vascath 9. Differentiate solutions used for CRRT 10. Discuss the safety precautions required for commencing CRRT 11. Differentiate pre dilution from post dilution 12. State the complications of CRRT 13. Describe methods that optimise clearance of fluid and waste 14. Describe methods of prolonging filter life 15. Discuss the indications for ceasing therapy 16. Recognise common reasons for CRRT machine alarms 17. Discuss the nursing management of the patient on CRRT
A Brief Look at Renal Anatomy & Physiology
Structures of the Renal System: The renal system is comprised of the Kidneys and those structures including the ureters, bladder and urethra that form the urinary system.
The primary role of the kidneys is to remove metabolic wastes and maintain fluid and electrolyte balance. The kidneys also have a role in: Blood Pressure Control Red Blood Cell Synthesis Bone Metabolism Acid- Base Balance
Renal dysfunction can negatively impact on all of these roles. 11
Adrenal Gland Ureter Kidney Bladder Urethra
The kidneys are situated in the retroperitoneum located between T12 and L3 on each side of the vertebral column. 12
Two layers form them internally. The outer layer is the Cortex that contains: Glomeruli Proximal Tubules Cortical Portions of Loops of Henle Distal Tubules Cortical Collecting Ducts 11,12
The inner layer or Medulla is comprised of Renal Pyramids. The pyramids contain: Medullary portions of Loops of Henle Medullary Portions of Collecting Ducts 12
Multiple pyramids taper and join forming a minor calyx. Several combined make a major calyx. The major calyces join and enter a funnel shaped renal pelvis that directs urine into the ureter. 11
Cross Section of the Kidney:
Components of the Nephron:
Approximately one million nephrons comprise each kidney. The nephron consists of: Glomerulus Bowman Capsule Proximal Convoluted Tubule Loop of Henle Distal Convoluted Tubule Collecting Duct 11,12
There are two types of nephron: Cortical Nephrons Juxtamedullary Nephrons 11
Cortical Nephrons: Approximately 85 % Perform excretory and regulatory functions 11
Juxtamedullary Nephrons: Approximately 15 % Responsible for concentration and dilution of urine 11
Urine Formation: Three processes required for urine formation include: Glomerular Filtration Tubular Reabsorption Tubular Secretion 11,12
Glomerulus Filters fluid and solutes from blood Proximal Convoluted Tubule Reabsorbs Na + , K + , Cl - , HCO 3 - , urea, glucose & amino acids Filtrate Continues Loop of Henle Reabsorbs Na + , K + & Cl -
Blocks reabsorption of H 2 O Dilutes/Concentrates Urine Filtrate Continues Distal Tubule Na + , K + , Ca ++ , PO 4 selectively reabsorbed H 2 O reabsorbed in presence of Antidiuretic Hormone (ADH) Filtrate Continues Collecting Duct Reabsorption similar to distal tubule HCO 3 - & H - reabsorbed/secreted to acidify urine Filtrate leaves hyperosmotic/hypoosmotic depending on the bodys requirements 11,12
Composition of Urine: H 2 O Electrolytes- Na + , K + , Cl - , HCO 3 - End products of protein metabolism- urea, creatinine, PO 4 , SO 4 End products of nucleic acid metabolism- uric acid Breakdown products of phosphoric and sulphuric acid H + ions excreted bound to buffers such as PO 4 and NH 3 11
Renal Anatomy & Physiology in Summary: Kidneys filter blood of waste products Functional units of the kidneys are called nephrons Nephrons consist of a glomerulus, tubule and collecting duct Urine is formed through glomerular filtration, tubular reabsorption and tubular secretion Urine moves from the collecting duct via the renal pelvis and ureters into the bladder, where it is excreted from the body through the urethra Some substances are reabsorbed into the blood and others excreted into the filtrate
Self Test 1
Q1. State the primary and secondary functions of the kidneys.
Q2. Name the functional units of the Kidneys and list their components.
Q3. Discuss the processes involved in urine formation
Summary of Acute Renal Failure
Definition:
Acute renal failure (ARF) is a clinical syndrome, characterised by an abrupt decline in glomerular filtration rate (GFR). There is a subsequent retention of metabolic waste products and an inability to maintain electrolyte and acid-base homeostasis. Regulation of fluid volume is also affected. 1,7,8,16,18,23
ARF occurs rapidly resulting in fifty percent or more nephrons to lose function, and as this occurs quickly the body is unable to compensate. There are three classifications of ARF based on the location of the cause. 23
Prerenal
Renal dysfunction is largely related to systemic factors that limit blood flow and reduce glomerular filtration rate. Examples include: Hypotension Hypovolaemic shock- dehydration, blood loss Cardiogenic shock post MI Septic Shock Bilateral renal vascular obstruction- thrombosis 1,8,9,16,18,23
Intrarenal
Renal impairment occurs secondary to damage that is sustained at the site of the nephrons. This may be the result of a number of conditions or nephrotoxins: Acute Tubular Necrosis (ATN) Acute Glomerulonephritis Acute Pyelonephritis Acute Cortical Necrosis Malignant Hypertension Acute Vasculitis Rhabdomyolysis - drugs, trauma Nephrotoxins - IV contrast, aminoglycosides 1,8,9,16,18,23
Postrenal
Renal failure secondary to obstruction that prevents excretion of urine Prostatic Hypertrophy Renal Calculi Tumour Blocked Urinary Catheter 1,8,9,16,18,23
Signs & Symptoms
Fluid and electrolyte abnormalities Metabolic acidosis Anaemia Pruritis secondary to uremic frost Nausea & vomiting Confusion LOC Congestive heart failure resulting in acute pulmonary oedema 1,8,16,18,23
Self Test 2
Q1. Define Acute Renal Failure
Q2. Describe 3 forms of acute renal failure and the associated causes
Q3. List the signs and symptoms of acute renal failure
Renal Replacement Therapy
Renal replacement therapy (RRT) is an extracorporeal technique of blood purification. Blood passes over a semipermeable membrane (filter) allowing solutes and water to cross over to a collection side. There are various modalities included under the umbrella of RRT. 19
Better for haemodynamic instability Readily accessible Effective fluid removal and clearance of solutes Can be performed by ICU staff rather than specialised renal nurses 2,4,5,9,17,20
Disadvantages:
Patient mobilisation is limited Access complications Anticoagulation Reduced blood flow rates secondary to small filters when compared to IHD 2,4,5,9,17,20
Intermittent Haemodialysis (IHD)
Advantages:
Quick and effective Large amounts of fluid and solutes can be removed over a short period 5,9
Disadvantages:
Access Complications- formal access such as A.V. Fistula is eventually required Requires specialised staff and is therefore not readily accessible May not be well tolerated by haemodynamically unstable patients Intermittent fluid removal with IHD can be associated with fluid overload and increased electrolytes between treatments 5,9
Peritoneal Dialysis
This form of dialysis utilises the peritoneum as the semipermeable membrane.
Advantages: Comparatively Cheaper No anticoagulation required
No haemodynamic instability 5,9,24
Disadvantages: High incidence of peritonitis Slow clearance Access Formal access required (Tenkhoff catheter) Limitations on patient as it is required frequently 5,9,24
Continuous Renal Replacement Therapy (CRRT)
Indications Fluid Overload, pulmonary oedema Worsening Metabolic Acidosis Hyperkalaemia Worsening Azotaemia Drug overdoses Removal of toxins 9
Basic Principles The basic principles incorporated in the function of CRRT involve: Convection Diffusion Ultrafiltration Hydrostatic Pressure 2,4,9,17,20
Terminology
Diffusion The movement of small and middle molecule solutes from an area of high concentration to low concentration across a semipermeable-membrane. 5,9
22 Osmosis The movement of water from an area of high water concentration to an area of lower water concentration across a semi-permeable membrane. 5,9
22
Ultrafiltration The movement of water and solutes across a semipermeable membrane by solvent drag created by convection and hydrostatic pressure. 5,9
22
Convection Water flow across a semi-permeable membrane by hydrostatic pressure that drags solutes with it (the way a waterfall moves pebbles and sand) 9
Hydrostatic Pressure The force that pushes fluid and solutes across the membrane. The mechanical blood pump on the dialysis machine creates this. 5,9
Oncotic Pressure Plasma proteins including albumin, globulin and fibrinogen create the pulling pressure that favours fluid retention and opposes hydrostatic pressure. 5,9
Counter Current The flow of two fluids in opposing directions. The direction of dialysis flows opposite to that of blood flow maximising the concentration difference between blood and dialysate. 5
Dialysate A synthetic solute free solution used to achieve diffusive solute clearance 5
Effluent Erroneous term used to indicate the solute and solvent discarded form the patient. 9
Replacement Pre or post dilution fluid
Pre-dilution Administration of the replacement fluid into the circuit prior to the filter 5,9
Post-dilution Administration of replacement fluid into the circuit after the filter 5,9
SCUF Slow Continuous Ultrafiltration is the method used when fluid removal is the only objective. Dialysate and replacement fluids are not utilised. Maximum fluid removal is 2000ml/hr. 2,17,20
= pump
SCUF System Setup 13
CAVH/CVVH Continuous Venovenous Haemofiltration uses convective clearance to remove water and solutes. Replacement is used to replace ultrafiltrate. Maximum fluid removal is 1000ml/hr. 2,17,20
= pump
CVVH System Setup 13
CAVHD/CVVHD Continuous Venovenous Haemodialysis uses diffusion to remove fluid and solutes. Dialysate is pumped in a counter current to blood flow. Maximum fluid removal is 1000ml/hr. 2,17,20
= pump
CVVHD System Setup 13
CAVHDF/CVVHDF Continuous Venovenous Haemodiafiltration utilises both convection and diffusion to remove fluid and solutes. Dialysate and replacement is used. Maximum fluid removal is 1000ml/hr. 2,17,20
Maximum fluid and solute removal. Urea clearance approximately 25- 26ml/min.
Fluid Overload, pulmonary oedema Worsening Metabolic Acidosis Hyperkalaemia Worsening Azotaemia Drug overdoses Removal of toxins
NB: There are other forms of CRRT however the above are most applicable to LHS
Self Test 3
Q1. What is renal replacement therapy?
Q2. List advantages and disadvantages of continuous modalities compared to other forms of RRT
Q3. List Indications for CRRT
Q4. Describe the basic principles of fluid and solute removal involved in CRRT.
Q5. Describe the different modes of CRRT.
Vascular Access
Good access that allows high flow rates through the circuit is one of the key aspects in CRRT that effects blood flow, clearance and filter life.
Catheters
Blood Flow is proportional to the diameter of the catheter- i.e. the wider the tube the better the blood flow. 3,4 Therefore the largest diameter catheter should be utilised. Vascaths available in Liverpool ICU include. Gambro- 13fr ( 15cm &20cm) Niagra- 13.5Fr (15cm & 24cm) Gambro- 12Fr (15cm & 20cm) Arrow Triple Lumen- 12 Fr (20cm) Lumens are colour coded being red and blue. The red lumen is the arterial port also known as the access port. This lumen supplies blood from the patient to the filter. The blue lumen is the venous port also known as the return port. Blood is returned via this lumen from the filter to the patient. Differentiating these lumens is necessary when troubleshooting access or return pressure alarms on the CRRT machines. 5
Catheter Location
Typically the vessels utilised for vascaths are the Internal Jugular, Femoral and Subclavian veins. The choice of catheter site is dependant on many factors including:
Skill of the accessing clinician Size of the patient Mobility of the patient Anticipated Duration of therapy Presence of other intravenous lines Coagulopathy 3,4
Internal Jugular Vein
Advantages: Allows for patient mobility Easy to visualise insertion site
Disadvantages: Requires Chest Xray prior to use Kinking can occur when the patient moves their head Sometimes attains insubstantial blood flows secondary to variations in central filling and intrathoracic pressures. Positive pressure ventilation can make this more apparent. 3,4,5
Femoral Vein
Advantages: Easily accessible by most clinicians May allow greater blood flows
Disadvantages: Prone to kinking, more so in the obese patient Does not allow for patient mobility Difficult to visualise and dress insertion site Higher incidence of infection secondary to the proximity to intestinal flora. 3,4,5
Subclavian Vein
Advantages: Allows for patient mobility Easy to visualise and dress insertion site
Disadvantages: Requires Chest Xray prior to use Risk of pneumothorax on insertion Risk of subclavian stenosis, which can impair suitability for an A-V fistula on the affected side, if renal failure becomes chronic. Sometimes attains insubstantial blood flows secondary to variations in central filling and intrathoracic pressures. Positive pressure ventilation can make this more noticeable. 3,4,5
Nursing Care for the Access Device
Regularly inspect insertion site for signs of infection, haematoma and bleeding Apply standard precautions and aseptic technique whenever connecting or disconnecting lines to and from the catheter Clean catheter and site with 0.5% chlorhexidine once weekly and prn using an aseptic technique and cover with an occlusive dressing (IV 3000) When catheter is not in use lumens should be Heparin-Locked to prevent clotting within the catheter 5
NB: Form more information on care of a vas cath see policy- management of central venous access devices in appendix
Heparin-Lock for a Vas-Cath
Apply standard precautions and utilise aseptic technique Using 3 ampoules of 5000 units heparin in 1ml (15000 units/3ml) inject the stated amount (located on each port) of this solution into the Vas Cath port. Label lumens as Heparin Locked 9,10
Troubleshooting Access Device
Where the CRRT machine exhibits high-pressure alarms the problem may stem from a malfunctioning catheter. Assess catheter patency as follows:
Apply standard precautions and utilise aseptic technique Aspirate and flush 10ml of blood on the effected lumen to test resistance to blood flow. Further, flush 10ml 0.9% sterile normal saline. 22
Where resistance is present, a clot may be obstructing the catheter, but more likely it is positioned against the vessel wall. Slightly withdrawing or rotating the catheter may overcome this problem. Where this fails to resolve the problem the catheter must be changed. 5,9,21
NB: Swapping the lumens- i.e. attaching the access line to the return port and visa versa may also overcome this problem, however this can result in a significant reduction in clearance and is therefore not recommended. It can be used as a temporary measure to overcome access problems. 9
Self Test 4
Q1. What is the importance of adequate access?
Q2. Sate the appropriate name and functions of the red and blue lumens on a vascath
Q3. What are the three possible sites for vascath insertion? State the advantages and disadvantages of each.
Q4. How would you troubleshoot a vascath?
Q5. How would you heparin lock a vascath?
Preparation for Therapy
Orders & Equipment
Obtain a complete and correctly filled order for CRRT using the ICU CRRT prescription form. NB: Pre dilution or Post dilution set Obtain equipment according to ICU protocol Continuous Renal Replacement Therapy (CRRT) using the PRISMA MACHINE. NB: equipment for the PRISMA FLEX is identical except for the required set, compatible warming line and one extra bag of GAMBRO or HEMOSOL solution as ordered.
Please read and become familiar with this protocol in conjunction with this package. (See appendix)
Preparation of Fluids
Losses in ultrafiltrate through CVVH and CVVHDF require replacing. Replacement fluid should be a balanced electrolyte solution that will offset the convective loss of electrolytes and plasma water during haemofiltration. As stated earlier, replacement fluid is a pre or post dilution fluid. The fluids available for such purpose in Liverpool ICU include HEMOSOL and GAMBRO. These fluids are also used as dialysate in modalities where diffusive clearance is also involved (CVVHDF, CVVHD). 3 To maintain acid- base balance, it is necessary for these fluids to contain base that will provide a buffer. Typically lactate serves this purpose as it is converted to bicarbonate in the liver. 4, GAMBRO is the fluid that contains lactate as its buffer.
Lactate free solutions also exist where bicarbonate must be added immediately prior to use. 4, HEMOSOL is considered lactate free and thus requires the addition of bicarbonate prior to use. This is accomplished by breaking the seal within the bag to mix the solutions together.
HEMOSOL is the fluid of choice where the patient is severely acidotic or suffering liver dysfunction that would prevent the metabolism of lactate to bicarbonate. Utilising GAMBRO in this circumstance may contribute to a worsening acidosis.
Specific to Dialysate
Both GAMBRO and HEMOSOL solutions require addition of KCL when used as dialysate. KCL is added to these fluids to reduce loss K + of through diffusion. NB: KCL is only added to these fluids when patients K + level is <5mmol/L.
Procedure
GAMBRO- Add 15mmol K + to 5L (already contains 5mmol K +/ 5L) HEMOSOL- Add 20mmol K + to 5L (Contains no K + )
Addition of K + in these quantities will make a final concentration of 4mmol K + /L. 9
Priming The Circuit
Both PRISMA and PRISMA FLEX machines contain on screen step by step instructions for setting up and priming the circuit. For further information on priming the PRISMA machine consult ICU protocol, Continuous Renal Replacement Therapy (CRRT) using the PRISMA MACHINE. Further information regarding the same processes for the PRISMA FLEX can be found in the operators manual located on the back of the machine. Failing this, please consult a senior staff member or educator that may assist you.
Access
Once the circuit is primed and ready to connect, 5ml of blood should be aspirated and discarded to remove heparin from the line. The vascath should then be checked for patency as described earlier in troubleshooting access device. It is important that therapy with a good circuit not be commenced on inadequate access. Circuits are expensive and poor access will significantly reduce its functional duration. Always apply aseptic technique when accessing catheter. 9
Commencing Therapy
Providing access is adequate, access and return lines can be connected to the corresponding lumens of the vascath using standard precautions and aseptic technique. A full breakdown of this procedure is located in ICU protocol Continuous Renal Replacement Therapy (CRRT) using the PRISMA MACHINE.
Connecting Patient to CRRT (Running pt on)
Once patient is connected select desired flow rates for Dialysate, Replacement, Blood Pump Speed, Ultrafiltrate/Fluid removal according to order (Commence blood pump at 80-100ml/hr and increase as tolerated by patient) Assess patients haemodynamic status Commence therapy Administer 2500 units heparin bolus via the red port on the access line. Omit heparin bolus if patient is coagulopathic or has been on CRRT in the last 4 hours. Monitor patient for haemodynamic instability for 15-30 minutes post commencing therapy. Patient may experience a transient drop in blood pressure, that will therefore require adjustment of pump speed to compensate, depending on the sensitivity of the patient. 9,21
Safety
CRRT Machine should be plugged into an isolated power socket When commencing therapy, colloid on a pump giving set should be connected to patients intravenous access 10mg Metaraminol (Aramine) should be drawn up and readily available. 10mg of Aramine is prepared in 20ml of 0.9% sodium chloride. This in conjunction with colloid is precautionary, should the patient become hypotensive. If the patient is on inotropes, Aramine may not be necessary as blood pressure can be controlled with the existing inotropic drugs. 9,21
Pre-dilution or Post-dilution
Pre-dilution involves administering replacement fluid prior to the filter. This thereby reduces the viscosity of blood and hematocrit and in effect may aid in preventing filter clotting. Unfortunately this method also dilutes the concentration of solute in plasma, which can negatively impact on clearance. In order to optimise clearance of solutes, replacement rate must be increased in order to increase the rate of ultrafiltration. 3,9
Post-dilution therefore involves administering replacement fluid after the filter. This does not dilute solutes in plasma, however the ability for optimal clearance is lost when blood viscosity is not reduced and high flow rates are then difficult to achieve. With reduced blood flow comes reduced ultrafiltration. Utilising filters with larger surface areas in conjunction with this method may improve clearance. 9
Complications Hypotension that may result from aggressive fluid removal Electrolyte imbalances Cardiac Arrhythmias Anaemia secondary to haemolysis of red blood cells Thrombocytopaenia secondary to platelet aggregation in filter Hypothermia secondary to extracorporeal blood circulation Coagulopathy secondary to over heparinisation Infection (line sepsis) Heparin induced thrombocytopaenia 2,9,17,21
Self Test 5
Q1. What is the purpose of dialysate and replacement fluids?
Q2. State the two fluids available at Liverpool ICU for CRRT, including the major difference and the preparations required.
Q3. How do you prepare the vascath prior to commencing CRRT with a new circuit?
Q4. List the safety aspects of connecting and commencing therapy.
Q5. Differentiate pre dilution from post dilution including benefits and disadvantages.
Q6. List the complications of CRRT.
Optimising Clearance
Regardless of which CRRT machine is being used, optimising clearance is dependant on two factors. These include improving diffusion and convection/ultrafiltration.
Improving Diffusion
Using filters with larger surface areas is one means of improving diffusion. 6 Currently Liverpool ICU stock consists of M100 and ST 100 filter sets. The M100 circuits incorporate an AN69 hollow fiber filter. These filters are comprised of Acrylonitrile and sodium methallyl sulfonate copolymer and have a surface area of 0.9m 2 . The ST 100 sets are similar but have a surface area of 1.0 m 2 . The filter is comprised of identical materials, however also includes the surface treatment agent polyethylene imine. 14 This surface treatment aims to encourage heparin binding during priming that can ultimately reduce heparin requirements for anticoagulation of the circuit. This may also benefit patients who require heparin free dialysis. 15
A second means of improving diffusion involves utilising an appropriate dialysate fluid. Eg. Withholding addition of KCL to dialysate fluid when the patient is hyperkalaemic so that serum potassium concentration remains higher than that in the dialysate. K + will therefore be filtered off the patient from an area of high to low concentration.
Improving Convection/Ultrafiltration
Improving convection/ultrafiltration is largely accomplished through high flow rates (Dialysate, Replacement, Ultrafiltration & Blood Pump). As mentioned earlier pre dilution assists in achieving higher flow rates by reducing the viscosity of blood and hematocrit. Location and care of the vascath is also shown to influence flow considerably. 6,9
Prolonging Filter Life
Prolonging filter life simply refers to preventing the filter clotting and maintaining its functional ability to remove fluid and waste. Factors that prolong filter life include:
High blood flow rates Pre dilution and warming of fluid Adequate Access Anticoagulation 3,4,9
Anticoagulation
On priming the circuit 5000 units of heparin should be added to each 1L bag of warmed normal saline Unless the patient is coagulopathic or has been on CRRT in the past 4 hours, 2500 units of heparin should be administered as a bolus, via the red pre filter port of the access line, as therapy is commenced. A heparin infusion of 15000 units in 50ml 0.9% sodium chloride can be administered according to ICU HEPARIN SODIUM protocol for anticoagulation of the dialysis circuit via the designated anticoagulant line of the circuit. Aim for a pre filter APTT (from pre filter port or arterial line/patient) between 30-40 seconds. 10
NB: If patient is coagulopathic run heparin free CRRT- refer to protocol for further precautions.
NB: Full information for anticoagulation of the dialysis circuit is available in ICU HEPARIN SODIUM protocol. Please read and become familiar with this protocol in conjunction with this package. (See appendix)
Discontinuing CRRT (Running Patient Off)
Refers to ending therapy either temporarily or permanently
Indications When indications for CRRT are no longer present When return pressures are elevated associated with filter clotting When alarms are indicating poor clearance For procedures in theatre or CT 21
Procedure
1. Observe standard precautions and aseptic technique. Use sterile gloves when disconnecting lines from the Vascath. 2. Press 'stop' and choose to end treatment. The PRISMA will then prompt you to return blood to the patient after providing the following: Attach a secondary giving set to 500mL bag of normal saline, add three-way tap to the end of this line and prime. Connect the red access line of the PRISMA circuit to the three-way tap, using aseptic technique. Return blood by following on screen prompts Remove circuit as per onscreen prompts. 3. Flush each lumen of the Vascath with 10mL normal saline. 4. Heparin Lock as per protocol
NB: If only a temporary disconnection and filter is still viable then connect both lines to a three-way tap. Circuit can then be reconnected to patient as normal when recommencing therapy. 21
Self Test 6
Q1. What factors need to be manipulated in order to optimise clearance?
Q2. Describe methods of optimising clearance.
Q3. List four factors that can prolong filter life.
Q4. When would anticoagulation NOT be used?
Q5. What are the indications for terminating therapy?
Common Alarms & Troubleshooting
There are various alarms that occur on both CRRT machines available in Liverpool ICU. The most common are discussed. Troubleshooting options are available in operators manual and instruction cards attached to each machine. On screen prompts are also issued when alarms are triggered.
Access Pressure High
Possible Triggers include: Red clamps closed Blocked or kinked vascath secondary to clot or position Blocked or kinked access line High blood flow rate High airway pressures Patient coughing 9,13
Return Pressure High
Possible Triggers include: Blue clamps closed Blocked or kinked vascath secondary to clot or position Blocked or kinked return line High airway pressures Filter Clotting/Clotted 9,13
Treatment obviously involves correcting the above problems. Where filter clotting is a possibility blood should be returned ASAP
Access or Return Disconnect
Triggered by low pressure in either of the lines. May indicate disconnection somewhere in the circuit. Check that all lines are connected securely.
Air in Blood
Possible Triggers include: Fluid level in bubble trap below sensor Air in circuit Incomplete priming Return line not installed in Air detector Dirty sensor Leaking connection 9,13
NB: This alarm must not be bypassed. It is a protective mechanism against the possibility of air embolism. Do not override until troubleshooting procedures in operators manuals have been fully followed. 9,13
There are many alarms that may be triggered during CRRT. If in doubt follow the on screen prompts or refer to the operators manual for guidance. Most alarms that occur will be related to the following:
Vascath obstruction due to position of patient Access or return lines kinking or clotting Bag placement on scales is incorrect Clotting of the filter/circuit Poorly placed blood leak detector Air in the circuit Periodic self test failure 9,13
Diaphragm Reposition Procedure
13
13 Performed if pod is accidentally removed or machine alarms indicating problem
-ve Pods (Access & Effluent) Stop Pump Clamp line above & below pod Remove pod & clean port Inject maximum of 1cc normal saline into pod using 20 g needle Reinstall pod Resume therapy
+ve Pods (Filter & Return) Same as above Aspirate maximum of 1cc
Summary of Nursing Care for the Patient on CRRT
Continuous monitoring of haemodynamic parameters Pressure area care and hygiene needs Optimise blood pressure prior to commencing therapy Colloid and Metaraminol precautions when running patient on When anticoagulation is running an initial APTT should be checked 4 hours after commencing therapy. 6 hourly APTT is attended thereafter and heparin infusion titrated according to protocol Electrolytes, urea and creatine (EUC) and calcium, magnesium and phosphate (CMP) should be checked 2 hours after commencing therapy. 6 hourly EUC/CMP thereafter. Where electrolytes need replacing, do so in accordance with ICU electrolyte protocols. Strict monitoring of fluid balance to prevent excessive fluid losses when removing fluid- this should monitored hourly and documented on CRRT observation chart to prevent incorrect fluid removal secondary to scale malfunction. Attend CRRT observation chart monitoring pressures in particular that may warn of filter clotting or access problems Monitor Vascath site for signs of infection. Clean and dress as required as earlier described. Monitor patients temperature and actively warm using a bear hugger blanket if necessary Maintain standard precautions and aseptic technique when priming, connecting, disconnecting the circuit. This also applies when changing fluids or disposing of ultrafiltrate As with all intensive care patients the MFASTHUG pneumonic should be followed- i.e. Mouth care, Feeding, Analgaesia, Sedation, Thromboembolism prophylaxis, Elevated bed head, Stress ulcer prophylaxis and Glucose control + Gut- aperients etc 2,5,8,17,20
Self Test 7
Q1. List the common triggers for alarms on the CRRT machines.
Q2. How would you reposition the diaphragms on both positive and negative pressure pods when required?
Q3. What nursing care is necessary for the patient undergoing CRRT?
Answers
Self Test1
Q1. State the primary and secondary functions of the kidneys.
The primary role of the kidneys is to remove metabolic wastes and maintain fluid and electrolyte balance. The kidneys also have a role in Blood Pressure Control, Red Blood Cell Synthesis, Bone Metabolism and Acid- Base Balance.
Q2. Name the functional units of the Kidneys and list their components.
The functional units of the kidneys are known as nephrons. The nephron consists of a Glomerulus, Bowman Capsule, Proximal Convoluted Tubule, Loop of Henle, Distal Convoluted Tubule and Collecting Duct. Or Glomerulus, tubule and collecting duct.
Q3. Discuss the processes involved in urine formation
Three process involved in urine formation include Glomerular Filtration, Tubular Reabsorption and Tubular Secretion. Glomerular filtration occurs as blood passes through the glomerulus being filtered of fluid and solutes. Tubular reabsorption and secretion occurs progressively through the areas of the tubule. Fluid, electrolytes and waste products are excreted as filtrate depending on the bodys requirements.
Self Test2
Q1. Define Acute Renal Failure
Acute renal failure (ARF) is a clinical syndrome, characterised by an abrupt decline in glomerular filtration rate (GFR). There is a subsequent retention of metabolic waste products and an inability to maintain electrolyte and acid- base homeostasis. Regulation of fluid volume is also affected.
Q2. Describe 3 forms of acute renal failure and the associated causes
Prerenal ARF is largely related to systemic factors that limit blood flow and reduce glomerular filtration rate. Related causes may include hypotension, hypovolaemic shock, cardiogenic shock, septic shock and thrombosis that results in bilateral renal vascular obstruction.
Intrarenal ARF is the result of damage sustained at the site of the nephrons. This could be secondary to a number of conditions or nephrotoxins including: Acute tubular necrosis, acute glomerulonephritis, acute cortical necrosis, malignant hypertension, acute vasculitis, rhabdomyolysis, IV contrast and aminoglycosides.
Post renal ARF occurs secondary to obstruction that prevents excretion of urine. This may relate to prostatic hypertrophy, renal calculi, tumour or blocked urinary catheter.
Q3. List the signs and symptoms of acute renal failure
Fluid and electrolyte abnormalities Metabolic acidosis Anaemia Pruritis secondary to uremic frost Nausea & vomiting Confusion LOC Congestive heart failure resulting in acute pulmonary oedema
Self Test 3
Q1. What is renal replacement therapy?
Renal replacement therapy (RRT) is an extracorporeal technique of blood purification. Blood passes over a semipermeable membrane (filter) allowing solutes and water to cross over to a collection side. There are various modalities included under the umbrella of RRT.
Q2. List advantages and disadvantages of continuous modalities compared to other forms of RRT
Advantages: Better for haemodynamic instability Readily accessible Effective fluid removal and clearance of solutes Can be performed by ICU staff rather than specialised renal nurses
Disadvantages: Patient mobilisation is limited Access complications Anticoagulation Reduced blood flow rates secondary to small filters when compared to IHD
Q3. List Indications for CRRT
Fluid Overload, pulmonary oedema Worsening Metabolic Acidosis Hyperkalaemia Worsening Azotaemia Drug overdoses Removal of toxins
Q4. Describe the basic principles of fluid and solute removal involved in CRRT.
Diffusion involves the movement of small and middle molecule solutes from an area of high concentration to low concentration across a semipermeable- membrane. Convection occurs with water flow across a semi-permeable membrane by hydrostatic pressure that drags solutes with it (the way a waterfall moves pebbles and sand). Ultrafiltration is the movement of fluid and solutes across a semipermeable membrane secondary to convection or hydrostatic pressure. Positive pressure pushes the fluid across where negative pressure pulls the fluid across. The force that pushes fluid and solutes across the membrane is known as hydrostatic pressure. The mechanical blood pump on the dialysis machine creates this.
Q5. Describe the different modes of CRRT.
Slow Continuous Ultrafiltration utilises convection and ultrafiltration to remove fluid. It is indicated for fluid overload. SCUF does not require dialysate or replacement fluids.
Continuous Venovenous Haemofiltration incorporates convection and ultrafiltration to remove fluid and moderate solutes. Replacement fluid is used. This modality is indicated for moderate electrolyte imbalances, oliguria whilst receiving TPN or blood and for patients in septic shock.
Continuous Venovenous Haemodialysis filters via diffusion. Fluid is removed together with more aggressive solute removal. Replacement fluid is not used. CVVHD is warranted for fluid overload with haemodynamic instability, Azotaemia, electrolyte disturbances and acidosis.
Continuous Venovenous Haemodiafiltration uses both diffusive and convective processes. Both replacement and dialysate solutions are used for maximum fluid and solute removal. This mode of CRRT is indicated for fluid overload, pulmonary oedema, worsening metabolic acidosis, hyperkalaemia worsening Azotaemia, drug overdoses and removal of toxins
Self Test 4
Q1. What is the importance of adequate access?
Good access that allows high flow rates through the circuit is one of the key aspects in CRRT that effects blood flow, clearance and filter life.
Q2. State the appropriate name and functions of the red and blue lumens on a vascath
The red lumen is the arterial port also known as the access port. This lumen supplies blood from the patient to the filter. The blue lumen is the venous
port also known as the return port. Blood is returned via this lumen from the filter to the patient.
Q3. What are the three possible sites for vascath insertion? State the advantages and disadvantages of each.
Internal Jugular Vein
Advantages: Allows for patient mobility Easy to visualise insertion site
Disadvantages: Requires Chest Xray prior to use Kinking can occur when the patient moves their head Sometimes attains insubstantial blood flows secondary to variations in central filling and intrathoracic pressures. Positive pressure ventilation can make this more apparent.
Femoral Vein
Advantages: Easily accessible by most clinicians May allow greater blood flows
Disadvantages: Prone to kinking, more so in the obese patient Does not allow for patient mobility Difficult to visualise and dress insertion site Higher incidence of infection secondary to the proximity to intestinal flora.
Subclavian Vein
Advantages: Allows for patient mobility Easy to visualise and dress insertion site
Disadvantages: Requires Chest Xray prior to use Risk of pneumothorax on insertion Risk of subclavian stenosis, which can impair suitability for an A-V fistula on the affected side, if renal failure becomes chronic. Sometimes attains insubstantial blood flows secondary to variations in central filling and intrathoracic pressures. Positive pressure ventilation can make this more apparent.
Q4. How would you troubleshoot a vascath?
Using aseptic technique, assess catheter patency by aspirating and flushing 10ml of blood on the effected lumen to test resistance to blood flow. Further, flush 10ml 0.9% sterile normal saline. Where resistance is present, a clot
may be obstructing the catheter, but more likely it is positioned against the vessel wall. Slightly withdrawing or rotating the catheter may overcome this problem. Where this fails to resolve the problem the catheter must be changed. The lumens may be swapped, however this is only a temporary measure as there is a loss in clearance.
Q5. How would you heparin lock a vascath?
Apply standard precautions and utilise aseptic technique Using 3 ampoules of 5000 units heparin in 1ml (15000 units/3ml) inject the stated amount (located on each port) of this solution into the Vas Cath port. Label lumens as Heparin Locked
Self Test 5
Q1. What is the purpose of dialysate and replacement fluids?
Dialysate fluid is used as a means to encourage diffusive clearance. Replacement fluid is a pre or post dilution fluid used to replace losses in ultrafiltrate.
Q2. State the two fluids available at Liverpool ICU for CRRT, including the major difference and the preparations required.
GAMBRO is the fluid that contains lactate as its buffer. HEMOSOL is considered lactate free and thus requires the addition of bicarbonate prior to use. This is accomplished by breaking the seal within the bag to mix the solutions together. Both GAMBRO and HEMOSOL solutions require addition of KCL when used as dialysate. 15mmol K + is added to 5L of GAMBRO. 20mmol K + is added to 5L of HEMOSOL. Both make a final concentration of 4mmol K + /L. KCL is added to these fluids to reduce loss K + of through diffusion.
Q3. How do you prepare the vascath prior to commencing CRRT with a new circuit?
Once the circuit is primed and ready to connect, 5ml of blood should be aspirated and discarded to remove heparin from the line. Assess catheter patency by aspirating and flushing 10ml of blood on the effected lumen to test resistance to blood flow. Further, flush 10ml 0.9% sterile normal saline.
Q4. List the safety aspects of connecting and commencing therapy.
CRRT Machine should be plugged into an isolated power socket When commencing therapy, colloid on a pump giving set should be connected to patients intravenous access 10mg Metaraminol (Aramine) should be drawn up and readily available. This in conjunction with colloid is precautionary, should the patient become hypotensive. Inotropes can be titrated for control of hypotension, if the patient is on them rather than utilising Aramine.
Q5. Differentiate pre dilution from post dilution including benefits and disadvantages.
Pre-dilution involves administering replacement fluid prior to the filter. This thereby reduces the viscosity of blood and hematocrit and in effect may aid in preventing filter clotting. Unfortunately this method also dilutes the concentration of solute in plasma, which can negatively impact on clearance by reducing the diffusion gradient. In order to optimise clearance of solutes, replacement rate must be increased in order to increase the rate of ultrafiltration.
Post-dilution therefore involves administering replacement fluid after the filter. This does not dilute solutes in plasma, however the ability for optimal clearance is lost when blood viscosity is not reduced and high flow rates are then difficult to achieve. With reduced blood flow comes reduced ultrafiltration. Utilising filters with larger surface areas in conjunction with this method may improve clearance.
Q6. List the complications of CRRT.
Hypotension that may result from aggressive fluid removal Electrolyte imbalances Cardiac Arrhythmias Anaemia secondary to haemolysis of red blood cells Thrombocytopaenia secondary to platelet aggregation in filter Hypothermia secondary to extracorporeal blood circulation Coagulopathy secondary to over heparinisation Infection Heparin induced thrombocytopaenia
Self Test 6
Q1. What factors need to be manipulated in order to optimise clearance?
Regardless of which CRRT machine is being used, optimising clearance is dependant on two factors. These include improving diffusion and convection/ultrafiltration.
Q2. Describe methods of optimising clearance.
Using filters with larger surface areas and appropriate dialysate fluid can optimise diffusive clearance. Improving clearance via convection/ultrafiltration is largely accomplished through high flow rates (Dialysate, Replacement, Ultrafiltration & Blood Pump). Pre dilution assists in achieving higher flow rates by reducing the viscosity of blood and hematocrit. Location and care of the vascath is also shown to influence flow considerably.
Q3. List four factors that can prolong filter life.
High blood flow rates Pre dilution and warming of fluid Adequate Access Anticoagulation
Q4. When would anticoagulation NOT be used?
Anticoagulation is not used if the patient is coagulopathic. A heparin bolus is not given if the patient has had CRRT within the last 4 hours.
Q5. What are the indications for terminating therapy?
When indications for CRRT are no longer present When return pressures are elevated associated with filter clotting When alarms are indicating poor clearance For procedures in theatre or CT
Self Test 7
Q1. List the common triggers for alarms on the CRRT machines.
Vascath obstruction due to position of patient Access or return lines kinking or clotting Bag placement on scales is incorrect Clotting of the filter/circuit Poorly placed blood leak detector Air in the circuit Periodic self test failure
Q2. How would you reposition the diaphragms on both positive and negative pressure pods when required?
If the pump has not stopped with an alarm, it should first be stopped. Apply clamps above and below the affected pod. Remove the pod and clean the port. If the pod is negative (Access & Effluent), inject a maximum of 1cc normal saline using a 20g needle into the pod. Conversely, if the pod is positive then a maximum of 1cc should be aspirated from the pod. Following this step the pod can be reinstalled into the appropriate port and therapy resumed.
Q3. What nursing care is necessary for the patient undergoing CRRT?
Continuous monitoring of haemodynamic parameters Pressure area care and hygiene needs Optimise blood pressure prior to commencing therapy
Colloid and Metaraminol precautions when running patient on When anticoagulation is running an initial APTT should be checked 4 hours after commencing therapy. 6 hourly APTT is attended thereafter and heparin infusion titrated according to protocol Electrolytes, urea and creatine (EUC) and calcium, magnesium and phosphate (CMP) should be checked 2 hours after commencing therapy. 6 hourly EUC/CMP thereafter. Where electrolytes need replacing, do so in accordance with ICU electrolyte protocols. Strict monitoring of fluid balance to prevent excessive fluid losses when removing fluid- this should monitored hourly and documented on CRRT observation chart to prevent incorrect fluid removal secondary to scale malfunction. Attend CRRT observation chart monitoring pressures in particular that may warn of filter clotting or access problems Monitor Vascath site for signs of infection. Clean and dress as required as earlier described. Monitor patients temperature and actively warm using a bear hugger blanket if necessary Maintain standard precautions and aseptic technique when priming, connecting, disconnecting the circuit. This also applies when changing fluids or disposing of ultrafiltrate As with all intensive care patients the MFASTHUG pneumonic should be followed- i.e. Mouth care, Feeding, Analgaesia, Sedation, Thromboembolism prophylaxis, Elevated bed head, Stress ulcer prophylaxis and Glucose control + Gut- aperients etc
References
1. Agraharkar, M., Gupta, R., Agraharkar, A., & Workeneh, B.T. (2006). Acute renal failure, [Online]. Available: http://www.emedicine.com/med/topic1595.htm [2006, September 13].
2. Astle, S. (2001). A new direction for dialysis. RN. 64(7), 56-60, 62
3. Baldwin, I., Bridge, N., Elderkin, T. (1998). Nursing issues, practices and perspectives for the management of continuous renal replacement therapy in the intensive care unit. In Bonett, J., Hattley, S., & Bastick, M. Continuous renal replacement information package. A quick guide to CRRT. (pp1-41) Gosford: NSCCH.
4. Bellomo, R., Baldwin, I., Ronco, C. (2001). Atlas of haemofiltration. In Bonett, J., Hattley, S., & Bastick, M. Continuous renal replacement information package. A quick guide to CRRT. (pp1-41) Gosford: NSCCH.
5. Bonett, J., Hattley, S., & Bastick, M. (2005). Continuous renal replacement information package. A quick guide to CRRT. (pp1- 41) Gosford: NSCCH.
6. Brunet, S., Leblanc, M., Geadah, M., Parent, D., Courteau, S., & Cardinal, J. (1999). Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates. Am J Kidney Dis. 34, 486-492.
15. Hospal (No date). AN69ST membrane- the bioactive membrane [Online]. Available: http://193.15.174.148/index.html.
16. Kaplan, A.A. (2003). Renal failure. In F.S. Bongard, & D.Y. Sue. Current critical care diagnosis & treatment (2 nd Ed.). [Online]. Available: http://online.statref.com/TOC/TOC.aspx?FxId=5&SessionId=7 A4937EMGZBYBIEJ
17. Kaplow, R., & Barry, R. (2002). Continuous renal replacement therapies: a more gentle blood filtering technique allows for fewer complications. American Journal of Nursing. 102(11), 26- 33.
18. Lameire, N., Van Biesen, W., & Vanholder, R. (2005). Acute renal failure. The Lancet. 365(9457), 417.
19. Medtel. (No date). Kimal- Continuous renal replacement therapy workbook. In Bonett, J., Hattley, S., & Bastick, M. Continuous renal replacement information package. A quick guide to CRRT. (pp1-41) Gosford: NSCCH.
20. Paton, M. (2003). Continuous renal replacement therapy: slow but steady. Nursing 2003. 33(6), 48-50
21. Sommer, N., Edgtton-Winn, M., & Shunker, S. (2004). Continuous renal replacement therapy (CRRT) using the prisma machine. ICU protocol. Liverpool: LHS